News

Analyst Maintains Optimism on Las Vegas Sands Stock Growth

Analyst Maintains Optimism on Las Vegas Sands Stock Growth

Las Vegas Sands Corp Receives Positive Price Target Update

JPMorgan recently increased its price target for Las Vegas Sands Corp (NYSE: LVS) to $60 from a previous $53, while keeping an Overweight rating on the stock. This update suggests that analysts are viewing the company’s future positively, particularly concerning its earnings before interest, taxes, depreciation, and amortization (EBITDA), especially in Macau.

Positive Adjustments to Macau EBITDA Projections

The updated EBITDA forecast for the company's Macau properties for the third quarter has been set at $572 million, up slightly from $556 million. This prediction comes with the expectation that Las Vegas Sands would maintain a steady gross gaming revenue (GGR) market share of around 24%, coinciding with its recent second-quarter performances. The new estimates reflect a less dramatic decline in Macau GGR, with a 1.5% drop now anticipated instead of the prior expectation of a 3.0% decline.

Adjustments to Marina Bay Sands Projections

On the other hand, the estimate for the Marina Bay Sands reveals a slight reduction with the EBITDA projection lowered to $508 million from $512 million due to ongoing room renovations. However, analysts foresee an upswing in expectations for the fourth quarter of 2024, indicating potential growth.

Renovations Present Opportunities for Growth

JPMorgan's compelling perspective regarding Las Vegas Sands is fueled by the expectation of fewer disruptions from ongoing renovations at the Londoner property in Macau. Following its recent reopening, the renovated casino is forecasted to enhance revenue through new hotel rooms and other revenue-generating features, which will be introduced in phases throughout the fourth quarter of 2024 and into 2025. This renovation strategy is anticipated to elevate Las Vegas Sands above its competitors in the region.

Events Boost Investor Sentiment

The successful performance during the Golden Week, alongside upcoming investor events scheduled in Singapore for November and in Macau in the spring, is further viewed as a positive influence. These events are expected to enhance investor visibility and help normalize what many analysts consider an undemanding valuation multiple of the company.

Future Growth Prospects Are Encouraging

JPMorgan's forecast suggests a mid-teens growth rate in Macau for 2025, anticipating EBITDA could soar around $2.8 billion. The investment firm also noted that Las Vegas Sands has been consistently buying back shares, with quarterly buybacks ranging from $400 to $500 million. Additionally, analysts predict a promising market in Singapore, anticipating approximately 7% growth in 2025 following robust growth of mid-teens in 2024. This trajectory is projected to be underpinned by capital expenditures and expansion in the Singaporean market.

Las Vegas Sands Faces Mixed Analyst Opinions

Recently, Las Vegas Sands Corp encountered mixed feedback from various analysts regarding its performance. While its second-quarter outcomes fell short of expectations due to renovation disruptions in both Macau and Singapore, firm Macquarie maintained its Outperform rating, emphasizing the long-term benefits arising from ongoing upgrades. Similarly, Stifel retained a Buy recommendation for Las Vegas Sands despite voiced concerns regarding operations in Macau.

Cautious Outlook from Other Analysts

Meanwhile, CFRA downgraded Las Vegas Sands from a Buy to a Hold designation, adjusting the price target down to $51 from $55. This revision indicates a more cautious perspective on the company's future positioning, considering the heavy reliance on the Macau and broader Asian markets.

Broader Market and Development Opportunities

Despite mixed ratings, Wells Fargo predicts a promising fourth quarter for Las Vegas Sands, while Mizuho Securities has raised its target price to $52, sustaining an Outperform rating. The company recorded a remarkable 24% increase in gaming revenues from its Macau operations, and it is keeping options open for new opportunities in markets like New York, Texas, and Thailand.

InvestingPro Insights Reflect Strong Performance

The recent financial data aligns with the optimistic outlook presented by JPMorgan. As compiled by InvestingPro, Las Vegas Sands reported a remarkable 68.48% revenue growth over the last twelve months, coupled with a staggering 137.26% increase in EBITDA. Such financial resilience substantiates projections for ongoing growth in key markets like Macau and Singapore.

Gross Profit Margins Indicate Operational Efficiency

InvestingPro highlights that the company has achieved gross profit margins of 76.91% over the past year, showcasing operational efficiency, particularly within its high-margin gaming operations. Furthermore, the company shows solid financial health, with liquid assets comfortably surpassing short-term liabilities, thus ensuring it can support the renovations and expansions referenced in analysts' evaluations.

Frequently Asked Questions

What recent changes have been made to Las Vegas Sands' stock target?

JPMorgan has raised the stock price target of Las Vegas Sands from $53 to $60 while keeping an Overweight rating.

What factors contributed to JPMorgan's bullish outlook on Las Vegas Sands?

The positive sentiment is based on expected growth in Macau, reduced renovation disruptions, and strong performance indicators during key operational events.

How do the renovations at Las Vegas Sands affect its financial outlook?

While renovations have caused short-term disruptions, they are anticipated to enhance future revenues and growth prospects in key markets.

What is the EBITDA projection for Las Vegas Sands in 2025?

JPMorgan forecasts Las Vegas Sands' EBITDA to be around $2.8 billion for the year 2025.

What are some of the new markets Las Vegas Sands is exploring for development?

Las Vegas Sands is looking into new opportunities in markets including New York, Texas, and Thailand.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 143

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 150

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 53

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 189

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 107

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Laurie Jennings to be Honored with Trish Bell Award in 2025

Updated Category News Views 600

Laurie Jennings to be Honored During Fashion Luncheon Chapman Partnership is thrilled to announce that six-time Emmy Award-winning journalist, Laurie Jennings, will receive the Trish Bell Lifetime Achievement Award at the esteemed Take a Walk in Her Shoes Luncheon. This remarkable event is set to take place at Jungle Island in 2025. It will bring together a large number...

Continue Reading
LEIFRAS Co., Ltd. Sets Price for Initial Public Offering

Updated Category News Views 329

LEIFRAS Co., Ltd. Sets Price for Initial Public Offering LEIFRAS Co., Ltd. (the "Company" or "Leifras"), a prominent player in the sports sector, dedicated to promoting youth sports and community initiatives, has unveiled the pricing details for its Initial Public Offering (IPO). IPO Pricing and Details The Company plans to offer 1,250,000 American Depositary Shares...

Continue Reading
Insight into NCC Group plc's Recent Trading Activities

Updated Category News Views 206

Key Insights on NCC Group plc's Trading Activities In the bustling financial markets, transparency is paramount, particularly when it comes to the dealings of exempt principal traders. Today, we delve into the recent activities surrounding NCC Group plc, guided by Rule 8.5 of the Takeover Code. This code ensures that all parties involved maintain clarity in their trading...

Continue Reading
Equifax Unveils AI Advisory Service for Lenders' Success

Updated Category News Views 229

Empowering Lenders with Equifax Ignite AI Advisor Equifax has recently launched a transformative tool known as the Equifax Ignite AI Advisor, which is set to revolutionize how lenders operate. This innovative product aims to provide lenders with precise, actionable insights that can significantly improve decision-making processes and account growth. By leveraging advanced...

Continue Reading
Aligned Partners with AMD and USC ISI for AI Innovation

Updated Category News Views 196

Aligned Teams Up with AMD and USC ISI for AI Advancements Aligned, an innovator in AI infrastructure and scalable machine learning, has announced an exciting collaboration with AMD and USC ISI. This partnership aims to propel the development of MEGALODON, a groundbreaking large language model (LLM). By leveraging AMD's powerful Instinct™ MI300 GPUs and Aligned's...

Continue Reading